Kyushu University [Eiji Iwama (Associate Professor) Faculty of Medical Sciences, Department of Clinical Medicine]

Eiji Iwama

Last modified date：2024.04.09

Associate Professor / Department of Clinical Medicine
Faculty of Medical Sciences

2 Academic Activities

E-Mail　*Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.

Homepage

Phone

092-642-5378

Fax

092-642-5389

Academic Degree

Doctor of Medicine

Country of degree conferring institution (Overseas)

Field of Specialization

respiratory medicine, lung cancer

Total Priod of education and research career in the foreign country

00years00months

Research

Research Interests

lung cancer
keyword : lung cancer, EGFR-TKI inhibitor, antibody-drug conjugate
2012.04～2024.03.

Academic Activities

Reports

Show All Reports >>

Papers

Show All Papers >>

1.	Iwama E., Zenke Y., Sugawara S., Daga H., Morise M., Yanagitani N., Sakamoto T., Murakami H., Kishimoto J., Matsumoto S., Nakanishi Y., Goto K. & Okamoto I., Trastuzumab emtansine for patients with non–small cell lung cancer positive for HER2 exon-20 insertion mutations., European journal of Cancer, 162, 99-106, 2022.02.
2.	Iwama E, Goto Y, Murakami H, Harada T, Tsumura S, Sakashita H, Mori Y, Nakagaki N, Fujita Y, Seike M, Bessho A, Ono M, Okazaki A, Akamatsu H, Morinaga R, Ushijima S, Shimose T, Tokunaga S, Hamada A, Yamamoto N, Nakanishi Y, Sugio K, Okamoto I., Alectinib for patients with ALK rearrangement-positive non-small cell lung cancer and a poor performance status (Lung Oncology Group in Kyushu 1401), J Thorac Oncol., 12(7):1161-1166., 2017.07.
3.	Iwama E, Sakai K, Azuma K, Harada T, Harada D, Nosaki K, Hotta K, Ohyanagi F, Kurata T, Fukuhara T, Akamatsu H, Goto K, Shimose T, Kishimoto J, Nakanishi Y, Nishio K, Okamoto I.　Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations., Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations., Ann Oncol. , 28(1):136-141., 2017.01.

Presentations

Show All Presentations >>

1.	Eiji Iwama, ALK rearranged NSCLC; what's the best sequence?, 第61回日本肺癌学会学術集会, 2020.11.
2.	Eiji Iwama, Kazuko Sakai, Koichi Azuma, Daijiro Harada, Kaname Nosaki, Katsuyuki Hotta, Makoto Nishio, Takayasu Kurata, Tatsuro Fukuhara, Hiroaki Akamatsu, Koichi Goto, Takayuki Shimose, Junji Kishimoto, Yoichi Nakanishi, Kazuto Nishio and Isamu Okamoto, A Multicenter Prospective Biomarker Study to Explore Mechanisms of Afatinib Resistance Based on Digital PCR and Next Generation Sequencing, World Conference on Lung Cancer 2018, 2018.09.
3.	Iwama Eiji, Highly sensitive and quantitative detection of EGFR T790M mutation in tumor samples by nanofluidic digital PCR, 50th American Society of Clinical Oncology (ASCO), 2014.05.

Membership in Academic Society

Unauthorized reprint of the contents of this database is prohibited.